DERMA SCIENCES INC's ticker is DSCI and the CUSIP is 249827502. A total of 70 filers reported holding DERMA SCIENCES INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $5,293,000 | -26.0% | 635,450 | +2.6% | 0.36% | -18.0% |
| Q2 2014 | $7,156,000 | -10.4% | 619,110 | -1.7% | 0.44% | -6.7% |
| Q1 2014 | $7,988,000 | +55.6% | 629,990 | +32.8% | 0.48% | +68.6% |
| Q4 2013 | $5,134,000 | -3.7% | 474,510 | +10.1% | 0.28% | -15.0% |
| Q3 2013 | $5,333,000 | -9.0% | 430,810 | -1.9% | 0.33% | -14.4% |
| Q2 2013 | $5,862,000 | – | 439,160 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,148,292 | $13,275,000 | 5.90% |
| DAFNA Capital Management LLC | 384,794 | $4,448,000 | 4.22% |
| Consonance Capital Management LP | 1,451,692 | $16,782,000 | 2.50% |
| Broadfin Capital, LLC | 3,648,754 | $42,180,000 | 2.08% |
| Redmile Group, LLC | 600,677 | $6,944,000 | 0.84% |
| ORACLE INVESTMENT MANAGEMENT INC | 492,796 | $5,696,722,000 | 0.69% |
| Senvest Management, LLC | 593,665 | $6,863,000 | 0.60% |
| HealthCor Management, L.P. | 920,000 | $10,635,000 | 0.53% |
| Baker Brothers Advisors | 3,537,137 | $40,889,000 | 0.50% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 112,117 | $1,296,000 | 0.50% |